Agilent OpenLAB ECM puts you in control.
Take control of electronic content with Agilent OpenLAB ECM. Our OpenLAB Enterprise Content Management solution lets you manage and organize ALL electronic content regardless of the source.
Agilent OpenLAB ECM puts you in control. Reduce the time, effort and cost it takes to go from raw data to final insight. The Agilent OpenLAB Enterprise Content Management solution gives you the power to manage and organize ALL your electronic content including chromatographic data and spectra.
OpenLAB ECM gives you powerful search tools that make it easy to find all matching files, regardless of the source application. It comes standard with flexible security settings so you can control system access with ease and confidence. And it’s scalable and affordable which means it grows with your business needs. Plus it links directly to ChemStation.
Want to learn more about Agilent OpenLAB ECM? Now is the time to do it. Agilent is offering a FREE OpenLab ECM e-seminar so you can learn everything you need to know right at your desk, right on your PC. The seminar will focus on real world customer applications and stories so you can see how other labs are benefitting from taking control with OpenLAB ECM.Register now and learn how you can make faster decisions, lower operational costs and increase productivity.
FREE seminar takes place on March 31, 2009.
Presenting GC Data Comparisons to Laypersons to Understand Potential Courtroom Implications
January 6th 2025In forensic science, scientific testimony is routinely presented in court to juries who may have limited or no scientific background, putting law enforcement and defense personnel in the position of having to make rapid decisions in short timeframes based on findings of which they are not specialists. Katelynn Perrault Uptmor, Assistant Professor of Chemistry at William & Mary (Williamsburg, Virginia) believes that the introduction of new technologies into the framework of routine forensic analysis must therefore bridge the gap between introduction of new and novel analytical science and the communication of that science to a court of law, and that analytical chemistry research must be mindful of the need to fill this gap in promoting new technologies.
Detailed Glycosylation Analysis of Therapeutic Enzymes Utilizing Comprehensive 2D-LC–MS
January 3rd 2025In this article, the use of comprehensive two-dimensional liquid chromatography (LC×LC) coupled to mass spectrometry (MS) for characterizing glycosylation of therapeutic enzymes is presented.
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), continue to make progress in both primate and first-in-human trials. As this progress builds, the industry remains accountable for characterizing these molecules to meet the requirements of regulatory authorities.
